Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Inmune Bio (INMB) Return on Assets (2019 - 2025)

Inmune Bio's Return on Assets history spans 7 years, with the latest figure at 1.45% for Q3 2025.

  • For Q3 2025, Return on Assets fell 66.0% year-over-year to 1.45%; the TTM value through Sep 2025 reached 1.45%, down 66.0%, while the annual FY2024 figure was 0.88%, 45.0% down from the prior year.
  • Return on Assets for Q3 2025 was 1.45% at Inmune Bio, up from 1.49% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.19% in Q1 2021 and bottomed at 1.49% in Q2 2025.
  • The 5-year median for Return on Assets is 0.36% (2023), against an average of 0.58%.
  • The largest annual shift saw Return on Assets increased 12bps in 2021 before it plummeted -73bps in 2025.
  • A 5-year view of Return on Assets shows it stood at 0.28% in 2021, then dropped by -12bps to 0.31% in 2022, then plummeted by -59bps to 0.5% in 2023, then crashed by -86bps to 0.92% in 2024, then crashed by -57bps to 1.45% in 2025.
  • Per Business Quant, the three most recent readings for INMB's Return on Assets are 1.45% (Q3 2025), 1.49% (Q2 2025), and 1.07% (Q1 2025).